Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of SAMe in Patients With Alcoholic Liver Disease

NCT00573313 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00573313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of SAMe in Patients With Alcoholic Liver Disease
Lead sponsor
University of California, Davis
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2005
Completion date
September 30, 2009
Enrollment
94 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver disease, alcoholic